The United States has moved to reclassify marijuana as a less dangerous drug in a historic shift that sent shares in cannabis firms soaring.
The US Justice Department’s recommendation on Tuesday that cannabis be classified as a schedule three drug – the same as ketamine and Tylenol with codeine – does not legalise recreational use outright, but opens the way to lighter punishments as well as greater private investment and tax benefits for the industry.
